STOCK COMPENSATION (Tables)

9 Months Ended

Dec. 31, 2023

Equity [Abstract]

Schedule of share-based compensation expense

	Three Months Ended December 31,   2023			Three Months Ended December 31,   2022			Nine Months Ended December 31, 2023			Nine Months Ended December 31, 2022
Vesting of stock options and restricted stock units	$	572,955		$	262,613		$	1,080,250		$	791,588
Total stock-based compensation expense	$	572,955		$	262,613		$	1,080,250		$	791,588
Weighted average number of common shares outstanding – basic and diluted		2,516,511			2,294,649			2,477,282			1,974,146
Basic and diluted loss per common share attributable to stock-based compensation expense	$	(0.23	)	$	(0.11	)	$	(0.44	)	$	(0.40	)

Schedule of options outstanding that have vested and are expected to vest

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years
Vested		106,862	$	24.85		7.30
Expected to vest		36,036	$	14.92		7.99
Total		142,898

Schedule of stock option activity

	Amount		Range of Exercise Price		Weighted Average Exercise Price
Stock options outstanding at March 31, 2023		171,826	$	6.90 – 1,425	$	22.39
Exercised		–	$	–	$	–
Granted		–	$	–	$	–
Cancelled/Expired		28,934	$	12.10 – 750	$	21.07
Stock options outstanding at December 31, 2023		142,898	$	6.90 – 1,425	$	22.34
Stock options exercisable at December 31, 2023		106,862	$	12.80 – 1,425	$	24.85